1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Heart failure drug passes Phase 2 trials – U-T San Diego

May 23, 2013Organ Failureadmin

Heart failure drug passes Phase 2 trials
U-T San Diego
An experimental heart failure drug being developed by Zensun Sci & Tech improved heart function in five Phase 2 clinical trials, the biotech company said today. Zensun, based in Shanghai, China, is preparing to talk with the U.S. Food and Drug ...
Zensun Announces Positive Clinical Results for Neucardin(TM) to Improve Heart ...MarketWatch (press release)

all 3 news articles »

Post navigation

← Non-Hodgkin lymphoma survival doubles since early 1970s – Medical Xpress Thoratec, A Bio Stock With Good Potential And Products – Seeking Alpha →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos